Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist
| Autor: | Kramer, J.A, Curran, D *, Piccart, M, de Haes, J.C.J.M, Bruning, P.F, Klijn, J.G.M, Bontenbal, M, van Pottelsberghe, C, Groenvold, M, Paridaens, R |
|---|---|
| Zdroj: | In European Journal of Cancer 2000 36(12):1488-1497 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect